These emerging treatments, Tirzepatide , represent a significant advancement in managing metabolic dysfunction and potentially other ailments . These drugs are grouped as GLP-1 hormone agonists , signifying they function to emulate the body's GLP-1 substance , boosting insulin release and suppres